Ticker League

Cash on Hand for ResMed (RMD)

As of · Reported

Metric

Latest period

$1.66B

YoY change

+407.4%

5Y CAGR

+21.2%

Peak year (2025)

$1.21B

Cash on Hand history chart for ResMed (RMD) from 1993 to 2025

Latest: $1.21B

Cash on Hand growth chart for ResMed (RMD) from 1993 to 2025

Latest: +407.4%

Cash on Hand history table for ResMed (RMD) from 1993 to 2025

  • 2025$1.21B+407.4%
  • 2024$238.36M+4.6%
  • 2023$227.89M-16.7%
  • 2022$273.71M-7.3%
  • 2021$295.28M-36.2%
  • 2020$463.16M+214.8%
  • 2019$147.13M-22.0%
  • 2018$188.70M-77.0%
  • 2017$821.93M+12.4%
  • 2016$731.43M+2.0%
  • 2015$717.25M-20.8%
  • 2014$905.73M+3.4%
  • 2013$876.05M+8.2%
  • 2012$809.54M+10.1%
  • 2011$735.27M+50.4%
  • 2010$488.78M+17.6%
  • 2009$415.65M+29.5%
  • 2008$321.08M+15.6%
  • 2007$277.74M+26.5%
  • 2006$219.54M+54.4%
  • 2005$142.19M+0.9%
  • 2004$140.93M+16.4%
  • 2003$121.02M+30.4%
  • 2002$92.84M-9.6%
  • 2001$102.75M+367.8%
  • 2000$21.96M+31.5%
  • 1999$16.70M+7.7%
  • 1998$15.50M+70.3%
  • 1997$9.10M+65.5%
  • 1996$5.50M+66.7%
  • 1995$3.30M-10.8%
  • 1994$3.70M+117.6%
  • 1993$1.70M—

Cash on Hand values are taken from ResMed's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at ResMed (RMD)

According to ResMed's latest reported financial statements, the company's latest reported cash and short-term investments is $1.66B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

ResMed (RMD) most recent annual cash and short-term investments stands at $1.21B (2025) – surged 407.4% year-over-year.

Looking at the 2020–2025 (5 years) stretch, ResMed cash and short-term investments compounded at +21.2% per year, sustaining 2 straight years of year-over-year growth.

Across the available history, cash and short-term investments reached its high of $1.21B in 2025 and its low of $1.70M in 1993.

ResMed Cash on Hand by Year

ResMed Cash on Hand 2025: $1.21B

ResMed cash and short-term investments in 2025 was $1.21B, surged 407.4% from 2024. This figure represents the highest annual value in the available history.

ResMed Cash on Hand 2024: $238.36M

2024's cash and short-term investments for ResMed came in at $238.36M, edged up 4.6% from 2023.

ResMed Cash on Hand 2023: $227.89M

ResMed posted cash and short-term investments of $227.89M in 2023, declined 16.7% below 2022.

ResMed Cash on Hand 2022: $273.71M

In 2022, ResMed reported cash and short-term investments of $273.71M, declined 7.3% below 2021.

ResMed Cash on Hand 2021: $295.28M

ResMed cash and short-term investments in 2021 was $295.28M.

See more financial history for ResMed (RMD).

Sector peers by Cash on Hand

Healthcare peers of ResMed (RMD), ranked by their latest cash and short-term investments

Frequently asked questions

ResMed (RMD) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview